ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

りん酸ビス[(1-メチルエチル)フェニル]フェニル

Bis(isopropylphenyl) phenyl phosphate

HCID 34149
ノート反応
基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
28109-00-4
標準SMILES
CC(C)c1ccccc1OP(=O)(Oc1ccccc1)Oc1ccccc1C(C)C
InChIKey
RMNODSGCFHVNDC-UHFFFAOYSA-N
分子式
C24H27O4P
平均分子量
410.4 g/mol
単同位体質量
410.16469634

名称と識別子

優先名称
Bis(isopropylphenyl) phenyl phosphate
IUPAC
phenyl bis(2-propan-2-ylphenyl) phosphate
現地名
りん酸ビス[(1-メチルエチル)フェニル]フェニル
英語名
bis(isopropylphenyl) phenyl phosphate
分子式
C24H27O4P
分子量
410.442541

名称と別名

28109-00-4HSDB 6796Di(isopropylphenyl) phenyl phosphateEINECS 248-849-8Phosphoric acid, bis((1-methylethyl)phenyl) phenyl esterBIS(ISOPROPYLPHENYL) PHENYL PHOSPHATEPhosphoric acid, bis[(1-methylethyl)phenyl] phenyl esterRefChem:569136DTXSID9051957phenyl di(isopropylphenyl) phosphatePhosphoric acid, bis((1-methylethyl)phenyl) phenyl ester (9CI)BIS(ISOPROPYLPHENYL) PHENYL PHOSPHATE [HSDB]
名称をさらに表示
りん酸ビス[(1-メチルエチル)フェニル]フェニルsum of isomersBIS(ORTHO-ISO-PROPYL-PHENYL)PHENYLPHOSPHATEPhosphoric acid bis[(1-methylethyl)phenyl]phenyl esterDiisopropyltrisphenyl phosphate, TIPPP purified ion m/z 410 of technical grade
Phosphoric acid, bis((1methylethyl)phenyl) phenyl esterBIS(ISOPROPYLPHENYL) PHENYL PHOSPHATE (MIXED ISOMERS)Bis(2-isopropylphenyl) Phenyl Phosphate69500-29-4Bis(o-isopropylphenyl) phenyl phosphatephenyl bis(2-propan-2-ylphenyl) phosphate5821A722STPhosphoric acid, bis(2-(1-methylethyl)phenyl) phenyl ester

データベース識別子

CAS
28109-00-4、69500-29-4
PubChem CID
34149
DTXSID
DTXSID5073616
UNII
5821A722ST
EC Number
248-849-8
Nikkaji
J560.501F

物性

構造計算による物性

XLogP
7.2
極性表面積
44.8 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
8
重原子数
29
形式電荷
0
複雑度
495

実験および物理化学的性質

Chemical ClassesOther Classes -> Organophosphates, Other
Endocrine DisruptorsPotential endocrine disrupting compound

物理化学的性質

EPAの化学物質情報
Bis(isopropylphenyl) phenyl phosphate (28109-00-4)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory InformationTP - indicates a substance that is the subject of a proposed TSCA section 4 test rule.
Hazards SummaryEmergency medical treatment: Organophosphates; [HSDB] See Triorthocresyl phosphate. See Triphenyl phosphate.

毒性情報

Human Toxicity Excerpts · 2 件

Organophosphorus cmpd can produce dermal irritation but most are weak sensitizers. /Organophosphate cmpd/

A woman at 34 to 35 weeks' gestation presented in acute respiratory distress with cyanosis and tachypnea and bilateral rhonchi and crepitation. Her heart rate was 78 beats per minute and her blood pressure 120/80 mm Hg, with a fetal heart rate of 140 beats per minute. The mother was salivating markedly and her pupils were reduced to "pinpoint size." An uncorrected metabolic acidosis was diagnosed. Serum and erythrocyte acetylcholinesterase determinations were near zero. Cholinesterase inhibitor poisoning was felt to be the likely cause of disorders. Administration of atropine 2.4 mg intravenous bolus with infusion of 0.02 mg/kg/hr lead to unacceptable fetal tachycardia. The woman had shown increased cooperativeness and secretion control until the atropine had to be stopped. A cesarean section was performed for delivery of a hypotonic infant with a 1 min Apgar score of 3. The baby was mechanically ventilated for 2 days and required atropine therapy at 0.1 mg/kg/hr for 8 days. The mother required 8 days of mechanical ventilation and 11 days of atropine therapy. In this case, the infant appeared relatively less poisoned than the mother by a presumed organophosphate exposure. /Organophosphate poisoning/

Non-Human Toxicity Excerpts · 2 件

The signs of poisoning due to organophosphorus cmpd are those due to accumulation of acetylcholine & hence overstimulation of parasympathetic nervous system. It is usual to divide them under 3 headings: muscarinic, nicotinic & central. Muscarinic signs ... consist of hypersalivation, lacrimation, sweating & nasal discharge. Miosis, dyspnea, vomiting, diarrhea & frequency of urination ... Nicotinic effects consist of fasciculation of muscles, weakness & paralysis. Central nervous system effects include nervousness, apprehension, ataxia, convulsions & coma. Death is due to resp failure, or sometimes cardiac arrest. There is little difference between signs produced by different organophosphorus compounds, but route of absorption may influence one system more than another. /Organophosphorus cmpd/

化学と産業

薬理情報

Metabolism/MetabolitesThese chemicals are detoxified by cytochrome p450-mediated monooxygenases in the liver, but some metabolites are more toxic than parent cmpd ... Metabolites usually are detected from 12 to 48 hr postexposure. /Organophosphate cmpd/
Absorption, Distribution and ExcretionMost organophosphate compounds are ... absorbed from skin, conjunctiva, gastrointestinal tract, & lung. /Organophosphate compounds/

用途と製造

General Manufacturing InformationPhosphoric acid, bis[(1-methylethyl)phenyl] phenyl ester: INACTIVE

サプライヤー6 社

艾吉析科技(上海)有限公司17717235263 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

The potential of isopropyl triphenyl phosphate to produce delayed neurotoxicity in hens was examined using several techniques. Isopropyl triphenyl phosphate contained O,O,O-triphenyl phosphate (24%), O-O-isopropylphenyl O,O-diphenyl phosphate (25%), O,O-diisopropyl-phenyl O-phenyl phosphate (20%), O-O, p-diisopropylphenyl O,O-diphenyl phosphate (18%) and O-p-isopropylphenyl O,O-diphenyl phosphate (6%). Hens treated twice, 3 wk apart, with doses of isopropyl triphenyl phosphate as high as 11.7 g/kg showed no clinical signs of delayed neurotoxicity and only mild signs of general toxicity. Furthermore, none showed even subtle neurohistologic changes suggestive of delayed neurotoxicity. Isopropyl triphenyl phosphate produced dose-dependent inhibition of hen plasma cholinesterase and brain neurotoxic esterase. The study was continued because neurotoxic esterase inhibition has been shown to be a reliable predictor of organophosphates that produce delayed neurotoxicity. Isopropyl triphenyl phosphate was administered prior to tri-o-tolyl phosphate challenge in order to determine if it altered development of tri-o-tolyl phosphate delayed neurotoxicity. Isopropyl triphenyl phosphate neither enhanced nor reduced the onset or severity of neurotoxicity produced by tri-o-tolyl phosphate. The time-course for brain and spinal cord neurotoxic esterase inhibition by isopropyl triphenyl phosphate and tri-o-tolyl phosphate were compared and found to be different. The maximum brain neurotoxic esterase inhibition produced by isopropyl triphenyl phosphate (dose up to 11.7 g/kg) was never complete (always less than 90%), and spinal cord neurotoxic esterase inhibition was significantly less than that produced in the brain. In contrast, brain and spinal cord inhibition produced by 500 mg/kg tri-o-tolyl phosphate were equal and greater than 90%. This testing regimen showed that isopropyl triphenyl phosphate produced an effect on neurotoxic esterase at the biochemical level without producing clinical or neurohistologic abnormalities in treated hens. Furthermore, this biochemical effect was qualitatively different than that produced by the delayed neurotoxicant tri-o-tolyl phosphate. /Isopropyl triphenyl phosphate/

Antidote and Emergency Treatment · 1 件

A comatose patient who is diaphoretic, has pinpoint pupils and the odor of an insecticide on clothing or breath, and is noted to have muscle fasciculations represents the classic presentation of organophosphate poisoning. ... Specific steps in management include the following. 1. Decontamination. ... 2 Airway. Establish an airway if necessary. ... 3. Respiratory Status. Respiratory distress, in fact, is commonly found in these patients from multiple causes. ... 4. Cardiac Monitoring. ... 5. Cholinesterase Level. ... 6. Pralidoxime. Pralidoxime is the treatment of choice for organophosphate poisoning and should be used for nearly all patients with clinically significant orgnophosphate poisoning,particularly whose patients with muscular fasciculations and weakness. ... 7. Atropine. Atropine is the physiologic antidote for organophosphate poisoning. A trial dose of atropine should be instituted on clinical ground when one suspects organophosphate intoxication. /Organophosphate poisoning/

安全データ

tsca
TSCA listed
有毒物質データの
28109-00-4(Hazardous Substances Data)